Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Profiling of Epigenetic Features in Clinical Samples Reveals Novel Widespread Changes in Cancer.

Noberini R, Restellini C, Savoia EO, Raimondi F, Ghiani L, Jodice MG, Bertalot G, Bonizzi G, Capra M, Maffini FA, Tagliabue M, Ansarin M, Lupia M, Giordano M, Osti D, Pelicci G, Chiocca S, Bonaldi T.

Cancers (Basel). 2019 May 24;11(5). pii: E723. doi: 10.3390/cancers11050723.

2.

Paediatric malignant melanoma in Ireland: A population study and review of the literature.

Quinlan CS, Capra M, Dempsey M.

J Plast Reconstr Aesthet Surg. 2019 Apr 11. pii: S1748-6815(19)30161-5. doi: 10.1016/j.bjps.2019.03.041. [Epub ahead of print]

PMID:
31101426
3.

Efficacy of low-level laser for treatment of cancer oral mucositis: a systematic review and meta-analysis.

Anschau F, Webster J, Capra MEZ, de Azeredo da Silva ALF, Stein AT.

Lasers Med Sci. 2019 Feb 7. doi: 10.1007/s10103-019-02722-7. [Epub ahead of print]

PMID:
30729351
4.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.

Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N.

Eur J Cancer. 2019 Mar;109:36-50. doi: 10.1016/j.ejca.2018.11.027. Epub 2019 Jan 25.

5.

Content validity of the WorkHab functional capacity evaluation.

James C, MacKenzie L, Capra M.

Aust Occup Ther J. 2019 Jan 22. doi: 10.1111/1440-1630.12565. [Epub ahead of print]

PMID:
30671981
6.

Pharmacokinetics and Exposure-Response Analyses of Daratumumab in Combination Therapy Regimens for Patients with Multiple Myeloma.

Xu XS, Dimopoulos MA, Sonneveld P, Ho PJ, Belch A, Leiba M, Capra M, Gomez D, Medvedova E, Iida S, Min CK, Schecter J, Jansson R, Zhang L, Sun YN, Clemens PL.

Adv Ther. 2018 Nov;35(11):1859-1872. doi: 10.1007/s12325-018-0815-9. Epub 2018 Oct 29.

7.

Scurvy: an unusual complication of paediatric cancer treatment.

Irvine I, Walshe T, Capra M, Hayes R.

Skeletal Radiol. 2019 Jun;48(6):995-998. doi: 10.1007/s00256-018-3103-5. Epub 2018 Oct 29.

PMID:
30374635
8.

Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation.

Buccheri V, Barreto WG, Fogliatto LM, Capra M, Marchiani M, Rocha V.

Ann Hematol. 2018 Dec;97(12):2269-2278. doi: 10.1007/s00277-018-3503-6. Epub 2018 Oct 12. Review.

PMID:
30315344
9.

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR.

Spencer A, Lentzsch S, Weisel K, Avet-Loiseau H, Mark TM, Spicka I, Masszi T, Lauri B, Levin MD, Bosi A, Hungria V, Cavo M, Lee JJ, Nooka AK, Quach H, Lee C, Barreto W, Corradini P, Min CK, Scott EC, Chanan-Khan AA, Horvath N, Capra M, Beksac M, Ovilla R, Jo JC, Shin HJ, Sonneveld P, Soong D, Casneuf T, Chiu C, Amin H, Qi M, Thiyagarajah P, Sasser AK, Schecter JM, Mateos MV.

Haematologica. 2018 Dec;103(12):2079-2087. doi: 10.3324/haematol.2018.194118. Epub 2018 Sep 20.

10.

Revised antiemetics guidelines and the impact on nutritional status during induction chemotherapy in children with high-risk neuroblastoma.

Carroll C, Clinton F, Smith A, Fox A, Capra M, Pears J, Owens C.

Pediatr Blood Cancer. 2018 Dec;65(12):e27386. doi: 10.1002/pbc.27386. Epub 2018 Sep 19.

PMID:
30230225
11.

Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss.

Brock PR, Maibach R, Childs M, Rajput K, Roebuck D, Sullivan MJ, Laithier V, Ronghe M, Dall'Igna P, Hiyama E, Brichard B, Skeen J, Mateos ME, Capra M, Rangaswami AA, Ansari M, Rechnitzer C, Veal GJ, Covezzoli A, Brugières L, Perilongo G, Czauderna P, Morland B, Neuwelt EA.

N Engl J Med. 2018 Jun 21;378(25):2376-2385. doi: 10.1056/NEJMoa1801109.

12.

An unusual case of wheat dependent exercise induced anaphylaxis (WDEIA) triggered by Tri a 14 in a pediatric patient: a case report.

Capra ME, De Paulis NG, Montagni M, Peveri S, Savi E, Biasucci G.

Eur Ann Allergy Clin Immunol. 2018 Jul;50(4):187-189. doi: 10.23822/EurAnnACI.1764-1489.31. Epub 2017 Nov 23.

13.

Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN.

Kilday JP, Caldarelli M, Massimi L, Chen RH, Lee YY, Liang ML, Parkes J, Naiker T, van Veelen ML, Michiels E, Mallucci C, Pettorini B, Meijer L, Dorfer C, Czech T, Diezi M, Schouten-van Meeteren AYN, Holm S, Gustavsson B, Benesch M, Müller HL, Hoffmann A, Rutkowski S, Flitsch J, Escherich G, Grotzer M, Spoudeas HA, Azquikina K, Capra M, Jiménez-Guerra R, MacDonald P, Johnston DL, Dvir R, Constantini S, Kuo MF, Yang SH, Bartels U.

Neuro Oncol. 2017 Oct 1;19(10):1398-1407. doi: 10.1093/neuonc/nox056.

14.

Decreasing In-home Smoking of Adults-Results from a School-based Intervention Program in Viet Nam.

Huong LTT, Long TK, Anh LV, Cook M, Capra M.

AIMS Public Health. 2016 Oct 24;3(4):863-879. doi: 10.3934/publichealth.2016.4.863. eCollection 2016.

15.

Proton therapy in paediatric oncology: an Irish perspective.

Lee KA, O'Sullivan C, Daly P, Pears J, Owens C, Timmermann B, Ares C, Combs SE, Indelicato D, Capra M.

Ir J Med Sci. 2017 Aug;186(3):577-582. doi: 10.1007/s11845-016-1520-9. Epub 2016 Oct 15.

PMID:
27744643
16.

One to Watch: A Germ Cell Tumor Arising in an Undescended Testicle in Rubinstein-Taybi Syndrome.

Butler GH, Boyle M, Lynch SA, Ryan S, McDermott M, Capra M.

J Pediatr Hematol Oncol. 2016 Aug;38(6):e191-2. doi: 10.1097/MPH.0000000000000619.

PMID:
27322716
17.
18.

Corrigendum: Mutations in the transcriptional repressor REST predispose to Wilms tumor.

Mahamdallie SS, Hanks S, Karlin KL, Zachariou A, Perdeaux ER, Ruark E, Shaw CA, Renwick A, Ramsay E, Yost S, Elliott A, Birch J, Capra M, Gray J, Hale J, Kingston J, Levitt G, McLean T, Sheridan E, Renwick A, Seal S, Stiller C, Sebire N, Westbrook TF, Rahman N.

Nat Genet. 2016 Apr;48(4):473. doi: 10.1038/ng0329-473d. No abstract available.

PMID:
27023775
19.

First report of imatinib measurement in hair: Method development and preliminary evaluation of the relation between hair and plasma concentrations with therapeutic response in chronic myeloid leukemia.

Capron A, Antunes MV, Wagner SC, Mattevi VS, Vieira N, Leite R, Reginato F, Capra M, Fogliatto L, Wallemacq P, Linden R.

Clin Chim Acta. 2016 Jan 30;453:42-7. doi: 10.1016/j.cca.2015.11.032. Epub 2015 Dec 3.

PMID:
26657979
20.

Mutations in the transcriptional repressor REST predispose to Wilms tumor.

Mahamdallie SS, Hanks S, Karlin KL, Zachariou A, Perdeaux ER, Ruark E, Shaw CA, Renwick A, Ramsay E, Yost S, Elliott A, Birch J, Capra M, Gray J, Hale J, Kingston J, Levitt G, McLean T, Sheridan E, Renwick A, Seal S, Stiller C, Sebire N, Westbrook TF, Rahman N.

Nat Genet. 2015 Dec;47(12):1471-4. doi: 10.1038/ng.3440. Epub 2015 Nov 9. Erratum in: Nat Genet. 2016 Apr;48(4):473.

PMID:
26551668
21.

Genomic Diversity of Phages Infecting Probiotic Strains of Lactobacillus paracasei.

Mercanti DJ, Rousseau GM, Capra ML, Quiberoni A, Tremblay DM, Labrie SJ, Moineau S.

Appl Environ Microbiol. 2015 Oct 16;82(1):95-105. doi: 10.1128/AEM.02723-15. Print 2016 Jan 1.

22.

DBS sampling in imatinib therapeutic drug monitoring: from method development to clinical application.

Antunes MV, Raymundo S, Wagner SC, Mattevi VS, Vieira N, Leite R, Reginato F, Capra MZ, Fogliatto L, Linden R.

Bioanalysis. 2015;7(16):2105-17. doi: 10.4155/bio.15.101.

PMID:
26327189
23.

Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients.

Pepe A, Meloni A, Borsellino Z, Cuccia L, Borgna-Pignatti C, Maggio A, Restaino G, Gagliardotto F, Caruso V, Spasiano A, Filosa A, Centra M, D'Ascola D, Quarta A, Peluso A, Midiri M, Rossi G, Positano V, Capra M.

J Cardiovasc Med (Hagerstown). 2015 Oct;16(10):689-95. doi: 10.2459/JCM.0000000000000278.

PMID:
26090920
24.

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M; EURAMOS collaborators.

Ann Oncol. 2015 Feb;26(2):407-14. doi: 10.1093/annonc/mdu526. Epub 2014 Nov 24.

25.

Rhabdoid tumor: the Irish experience 1986-2013.

Uwineza A, Gill H, Buckley P, Owens C, Capra M, O'Sullivan C, McDermott M, Brett F, Farrell M, Pears J, O'Sullivan MJ.

Cancer Genet. 2014 Sep;207(9):398-402. doi: 10.1016/j.cancergen.2014.05.015. Epub 2014 Jun 11.

PMID:
25085603
26.

Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial.

van Rhee F, Wong RS, Munshi N, Rossi JF, Ke XY, Fosså A, Simpson D, Capra M, Liu T, Hsieh RK, Goh YT, Zhu J, Cho SG, Ren H, Cavet J, Bandekar R, Rothman M, Puchalski TA, Reddy M, van de Velde H, Vermeulen J, Casper C.

Lancet Oncol. 2014 Aug;15(9):966-74. doi: 10.1016/S1470-2045(14)70319-5. Epub 2014 Jul 17. Erratum in: Lancet Oncol. 2014 Sep;15(10):417.

PMID:
25042199
27.

Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry.

Borgna-Pignatti C, Garani MC, Forni GL, Cappellini MD, Cassinerio E, Fidone C, Spadola V, Maggio A, Restivo Pantalone G, Piga A, Longo F, Gamberini MR, Ricchi P, Costantini S, D'Ascola D, Cianciulli P, Lai ME, Carta MP, Ciancio A, Cavalli P, Putti MC, Barella S, Amendola G, Campisi S, Capra M, Caruso V, Colletta G, Volpato S.

Br J Haematol. 2014 Oct;167(1):121-6. doi: 10.1111/bjh.13009. Epub 2014 Jul 3.

PMID:
24992281
28.

Congenital-infantile fibrosarcoma of the foot--avoidance of amputation.

Nason GJ, Baker JF, Seoighe D, Irvine AD, McDermott M, Orr D, Capra M, Kelly PM.

Ir Med J. 2014 May;107(5):148-9.

PMID:
24908860
29.

Erythrocyte-exchange with the OPTIA™ cell separator in patients with sickle-cell disease.

Perseghin P, Incontri A, Capra M, Pichler H, Witt V.

J Clin Apher. 2013 Dec;28(6):411-5. doi: 10.1002/jca.21293. Epub 2013 Sep 2.

PMID:
24000045
30.

Resolution of the plantar hyperkeratosis of pachyonychia congenita during chemotherapy for Ewing sarcoma.

Higgins E, Capra M, Schwartz ME, Smith FJ, McLean WH, Irvine AD.

Br J Dermatol. 2013 Dec;169(6):1357-60. doi: 10.1111/bjd.12574. No abstract available.

31.

A safety and feasibility study with platelet lysate expanded bone marrow mesenchymal stromal cells for the treatment of acute graft-versus-host disease in Brazil.

Silla L, Valim V, Amorin B, Alegretti AP, Dos Santos de Oliveira F, Lima da Silva MA, Dahmer A, Emerim Lemos N, Mentz Albrecht MA, Macedo Laureano Á, Bonfim C, Moraes Júnior L, Pezzi A, Baggio L, Albrecht CA, Capra M, Fogliatto L, Della Costa Rigoni L, Fischer G, Paz A, Esteves Daudt L.

Leuk Lymphoma. 2014 May;55(5):1203-5. doi: 10.3109/10428194.2013.823495. Epub 2013 Aug 28. No abstract available.

PMID:
23844820
32.

Erythrocyte-exchange in sickle-cell disease patients. A comparison between Caridian COBE Spectra and Optia cell separators.

Perseghin P, Incontri A, Capra M.

Transfus Apher Sci. 2013 Apr;48(2):177. doi: 10.1016/j.transci.2013.02.025. Epub 2013 Mar 15. No abstract available.

PMID:
23809823
33.

Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major.

Filosa A, Vitrano A, Rigano P, Calvaruso G, Barone R, Capra M, Cuccia L, Gagliardotto F, Pitrolo L, Prossomariti L, Casale M, Caruso V, Gerardi C, Campisi S, Cianciulli P, Rizzo M, D'Ascola G, Ciancio A, Maggio A.

Blood Cells Mol Dis. 2013 Aug;51(2):85-8. doi: 10.1016/j.bcmd.2013.04.002. Epub 2013 Apr 28.

PMID:
23628348
34.

Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death.

Maggio A, Vitrano A, Calvaruso G, Barone R, Rigano P, Mancuso L, Cuccia L, Capra M, Pitrolo L, Prossomariti L, Filosa A, Caruso V, Gerardi C, Campisi S, Cianciulli P, Elefteriou A, Angastiniotis M, Hamza H, Telfer P, Walker JM, Phrommintikul A, Chattipakorn N.

Blood Cells Mol Dis. 2013 Apr;50(4):241-6. doi: 10.1016/j.bcmd.2012.12.002. Epub 2013 Jan 20.

PMID:
23337255
35.

Paediatric spinal glioblastoma: case report and review of therapeutic strategies.

O'Halloran PJ, Farrell M, Caird J, Capra M, O'Brien D.

Childs Nerv Syst. 2013 Mar;29(3):367-74. doi: 10.1007/s00381-013-2023-x. Epub 2013 Jan 15. Review.

PMID:
23319103
36.

Congenital sacrococcygeal PNET and chemotherapy.

Hawkes CP, Betts DR, O'Brien J, O'Sullivan MJ, Capra M.

Indian J Med Paediatr Oncol. 2012 Jul;33(3):182-4. doi: 10.4103/0971-5851.103151.

37.

Quantification of the safe maximal lift in functional capacity evaluations: comparison of muscle recruitment using SEMG and therapist observation.

James C, Mackenzie L, Capra M.

J Occup Rehabil. 2013 Sep;23(3):419-27. doi: 10.1007/s10926-012-9407-8.

PMID:
23224793
38.

An audit of chemotherapy-induced nausea and vomiting in children.

Clinton F, Dowling M, Capra M.

Nurs Child Young People. 2012 Sep;24(7):18-23.

PMID:
23155937
39.

Cytogenetic response to imatinib treatment in Southern Brazilian patients with chronic myelogenous leukemia and variant Philadelphia chromosome.

Koshiyama DB, Capra ME, Paskulin GA, Rosa RF, Oliveira CA, Vanelli T, Fogliatto LM, Zen PR.

Ann Hematol. 2013 Jan;92(2):185-9. doi: 10.1007/s00277-012-1598-8. Epub 2012 Oct 14.

PMID:
23064942
40.

Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients.

Maggio A, Vitrano A, Lucania G, Capra M, Cuccia L, Gagliardotto F, Pitrolo L, Prossomariti L, Filosa A, Caruso V, Gerardi C, Campisi S, Cianciulli P, Rizzo M, D'Ascola G, Ciancio A, Di Maggio R, Calvaruso G, Pantalone GR, Rigano P.

Am J Hematol. 2012 Jul;87(7):732-3. doi: 10.1002/ajh.23219. Epub 2012 May 24.

41.

Spermatogenesis in a prepubertal boy.

O'Grady MJ, McGrath N, Quinn FM, Capra ML, McDermott MB, Murphy NP.

J Pediatr. 2012 Aug;161(2):369-369.e1. doi: 10.1016/j.jpeds.2012.03.040. Epub 2012 May 9. No abstract available.

PMID:
22575252
42.

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience.

Maibach R, Roebuck D, Brugieres L, Capra M, Brock P, Dall'Igna P, Otte JB, De Camargo B, Zsiros J, Zimmermann A, Aronson D, Childs M, Scopinaro M, Morland B, Plaschkes J, Czauderna P, Perilongo G.

Eur J Cancer. 2012 Jul;48(10):1543-9. doi: 10.1016/j.ejca.2011.12.011. Epub 2012 Jan 13.

PMID:
22244829
43.

IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection.

Di Marco V, Bronte F, Calvaruso V, Capra M, Borsellino Z, Maggio A, Renda MC, Pitrolo L, Lo Pinto MC, Rizzo M, Fiorenza F, Gerardi C, Grimaudo S, Di Cristina A, Levrero M, Craxì A.

Haematologica. 2012 May;97(5):679-86. doi: 10.3324/haematol.2011.050351. Epub 2011 Dec 16.

44.

Ectomesenchymoma with t(1;12)(p32;p13) evolving from embryonal rhabdomyosarcoma shows no rearrangement of ETV6.

Howley S, Stack D, Morris T, McDermott M, Capra M, Betts D, O'Sullivan MJ.

Hum Pathol. 2012 Feb;43(2):299-302. doi: 10.1016/j.humpath.2011.03.010. Epub 2011 Jul 30.

PMID:
21803398
45.

Survival and long-term outcomes in children with hepatoblastoma treated with continuous infusion of cisplatin and doxorubicin.

Sivaprakasam P, Gupta AA, Greenberg ML, Capra M, Nathan PC.

J Pediatr Hematol Oncol. 2011 Aug;33(6):e226-30. doi: 10.1097/MPH.0b013e31821f0eaf.

PMID:
21792028
46.

The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients.

Ceci A, Mangiarini L, Felisi M, Bartoloni F, Ciancio A, Capra M, D'Ascola D, Cianciulli P, Filosa A.

Anemia. 2011;2011:435683. doi: 10.1155/2011/435683. Epub 2011 Jun 5.

47.

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up.

Cappellini MD, Bejaoui M, Agaoglu L, Canatan D, Capra M, Cohen A, Drelichman G, Economou M, Fattoum S, Kattamis A, Kilinc Y, Perrotta S, Piga A, Porter JB, Griffel L, Dong V, Clark J, Aydinok Y.

Blood. 2011 Jul 28;118(4):884-93. doi: 10.1182/blood-2010-11-316646. Epub 2011 May 31. Erratum in: Blood. 2011 Nov 3;118(18):5060.

48.

Isolation and phenotypic characterization of Lactobacillus casei and Lactobacillus paracasei bacteriophage-resistant mutants.

Capra ML, Mercanti DJ, Rossetti LC, Reinheimer JA, Quiberoni A.

J Appl Microbiol. 2011 Aug;111(2):371-81. doi: 10.1111/j.1365-2672.2011.05056.x. Epub 2011 Jun 6.

49.

Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large multicenter randomized clinical trial in -thalassemia major patients.

Pantalone GR, Maggio A, Vitrano A, Capra M, Cuccia L, Gagliardotto F, Filosa A, Romeo MA, Magnano C, Caruso V, Argento C, Gerardi C, Campisi S, Violi P, Malizia R, Cianciulli P, Rizzo M, D'Ascola DG, Quota A, Prossomariti L, Fidone C, Rigano P, Pepe A, D'Amico G, Morabito A, Gluud C.

Hemoglobin. 2011;35(3):206-16. doi: 10.3109/03630269.2011.570674.

PMID:
21599433
50.

Childhood cancer survival in Ireland: temporal, regional and deprivation-related patterns.

Walsh PM, Byrne J, Capra M, Comber H.

Eur J Cancer. 2011 Aug;47(12):1852-62. doi: 10.1016/j.ejca.2011.03.021. Epub 2011 Apr 27.

PMID:
21530237

Supplemental Content

Support Center